WO2004096830A1 - Synthesis of solanum glycosides - Google Patents
Synthesis of solanum glycosides Download PDFInfo
- Publication number
- WO2004096830A1 WO2004096830A1 PCT/EP2004/004629 EP2004004629W WO2004096830A1 WO 2004096830 A1 WO2004096830 A1 WO 2004096830A1 EP 2004004629 W EP2004004629 W EP 2004004629W WO 2004096830 A1 WO2004096830 A1 WO 2004096830A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- benzoyl
- acetyl
- sph
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Definitions
- the present invention relates to the chemical synthesis of solanum giycosides, in particular to the synthesis of solasonine as well as to novel ⁇ -monosaccharide intermediate compounds.
- Solasodine and its giycosides are of considerable interest clinically. They are widely used as starting products for the synthesis of various steroidal drugs, the aglycon solasodine is a source for synthetic cortisone and progesterone.
- solasodine giycosides have potent antineoplastic properties.
- solasonine 22R, 25R
- solasonine 22R, 25R
- solamargine 22R, 25R
- solamargine 22R, 25R
- solamargine 22R, 25R
- the above triglycosides are conventionally obtained by extraction from a plant source.
- a commercially available extract of S. sodomaeum commonly referred to as BEC (Drug Future, 1988, vol. 13.8, pages 714-716) is a crude mixture of solamargine, solasonine and their isomeric diglycosides.
- the extraction process for making BEC involves homogenizing the fruits of S. sodomaeum in a large volume of acetic acid, filtering off the liquid through muslin followed by precipitation of the giycosides with ammonia (Drugs of today (1990), Vol. 26 No. 1, p. 55-58, cancer letters (1991), Vol. 59, p. 183-192).
- the yield of the solasodine glycoside mixture is very low (approx. 1%).
- the individual process steps are not defined to GMP in terms of scale up, definition of yield, composition and product quality.
- the steroid skeleton of solasodine contains a very labile nitrogen-containing ring. This aglycon cannot readily be chemically modified while keeping the steroid skeleton intact.
- the prior art does not disclose the synthesis of the solasonine using the aglycon material as starting material.
- solasonine requires the stereoselective glycosylation of solasodine at the relatively unreactive hydroxyl group.
- solasodine is not compatible with the conventional steroid glycosylation technique. No glycosylation was observed following the treatment of solasodine with tetrabenzoyl -D-glucopyranosyl trichloroacetimidate and trimethyl-silyl triflate or boron trifluoride dietherate (unpublished results).
- the problem underlying the present invention is to provide a cost effective method for the preparation of solasonine.
- the present invention resides in the finding that the stereoselective ⁇ -glycosylation of solasodine may be achieved in high yields using specific galacto-pyranosyl donors.
- the reaction is carried out in the presence of a promoter.
- R Benzylidine, 4-nitrobenzylidine or 4-methoxybenzylidine
- R 2 Benzoyl, acetyl or pivolyl
- R 3 Halogen, SEt or SPh
- each R-j is the same or different and independently represents a benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene group
- each R2 is the same or different and independently represents a benzoyl, acetyl or pivaloyl group and
- R 3 is halogen, SPh or SEt
- each Ri is the same or different and independently represents a benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene group and each R 2 is the same or different and independently represents a benzoyl, acetyl or pivaloyl group.
- reaction is carried out in the presence of a promoter.
- Any conventional promoter as used in carbohydrate chemistry may be used.
- the reaction is preferably carried out using dichloromethane as the solvent.
- the reaction time is 30 min.-1 hr.
- the desired end product solasonine may be prepared by partially deprotecting the ⁇ -glycoside of formula 2 to give intermediate formula 3(1) and then selectively silylating one of the hydroxyl groups (OH-2 and OH-3) using tert-butyldimethylsilyl chloride, imidazole in DMF at 50°C.
- R1 Benzylidine, 4-nitrobenzylidine or 4-methoxybenzylidine
- each of Ri is the same or different and represent independently from each other benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene,
- R 2 is tert-butylsilyl or H and R 3 is H.
- the OH-3 protected galactose-solasodine adduct is then glycosylated at the OH-2 with a suitable ⁇ -L-rhamnopyranosyl donor.
- Suitable rhamnose donors include tri-O-benzolyl- -rhamnopyranosly, tri-O- pivoloyl-L-rhamnopyranosyl, or tri-O-acetyl- 4- L-rhamnopyranosyl bromides of formula 4
- R, Acetyl, benzoyl or pivolyl
- R 2 Halogen, SEt or SPh
- each of Ri is the same or different and independently represents acetyl, benzoyl or pivaloyl, and R 2 is halogen or SEt, SPh
- R., Acetyl, benzoyl or pivolyl
- R 2 Halogen, SEt or SPh
- each of Ri is the same or different an independently represents acetyl, benzoyl or pivaloyl and R 2 is halogen, SEt, SPh gives a fully protected solasonine of formula 6(1).
- each Ri is the same or different and independently represents benzylidene, 4-nitrobenzyilidene or 4-methoxybenzylidene and each R 2 are the same or different and independently represent acetyl, benzoyl or pivaloyl.
- the protected solasonine formula 6(1) may be de-acetalised using aqueous acetic acid at 70°C and de-esterified using sodium methoxide in methanol/dichloromethane mixture to give the fully deprotected solasonine formula 6(2) where in R and R 2 are H.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04730531A EP1618122A1 (en) | 2003-04-30 | 2004-04-30 | Synthesis of solanum glycosides |
CA002524131A CA2524131A1 (en) | 2003-04-30 | 2004-04-30 | Synthesis of solanum glycosides |
AU2004234071A AU2004234071A1 (en) | 2003-04-30 | 2004-04-30 | Synthesis of solanum glycosides |
JP2006505349A JP2006524664A (en) | 2003-04-30 | 2004-04-30 | Synthesis of solanam glycoside. |
US10/555,038 US7435816B2 (en) | 2003-04-30 | 2004-04-30 | Synthesis of solanum glycosides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03009725.7 | 2003-04-30 | ||
EP03009725 | 2003-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004096830A1 true WO2004096830A1 (en) | 2004-11-11 |
Family
ID=33395777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/004629 WO2004096830A1 (en) | 2003-04-30 | 2004-04-30 | Synthesis of solanum glycosides |
Country Status (6)
Country | Link |
---|---|
US (1) | US7435816B2 (en) |
EP (1) | EP1618122A1 (en) |
JP (1) | JP2006524664A (en) |
AU (1) | AU2004234071A1 (en) |
CA (1) | CA2524131A1 (en) |
WO (1) | WO2004096830A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005454A1 (en) * | 2003-07-08 | 2005-01-20 | Glycomed Sciences Limited | Steroid modified chacotrioses and solatrioses |
WO2005005449A2 (en) * | 2003-07-08 | 2005-01-20 | Glycomed Sciences Limited | Steroid modified solatrioses |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019026102A2 (en) * | 2017-06-12 | 2020-06-30 | Lignamed, Llc | processes for preparing a compound and a mixture of compounds |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003018604A1 (en) * | 2001-08-21 | 2003-03-06 | Glycomed Sciences Limited | Synthesis of solanum glycosides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19621177A1 (en) * | 1996-05-24 | 1997-11-27 | Basf Ag | Carbohydrate derivatives and their synthesis on solid phase |
-
2004
- 2004-04-30 AU AU2004234071A patent/AU2004234071A1/en not_active Abandoned
- 2004-04-30 CA CA002524131A patent/CA2524131A1/en not_active Abandoned
- 2004-04-30 US US10/555,038 patent/US7435816B2/en not_active Expired - Fee Related
- 2004-04-30 WO PCT/EP2004/004629 patent/WO2004096830A1/en active Application Filing
- 2004-04-30 EP EP04730531A patent/EP1618122A1/en not_active Withdrawn
- 2004-04-30 JP JP2006505349A patent/JP2006524664A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003018604A1 (en) * | 2001-08-21 | 2003-03-06 | Glycomed Sciences Limited | Synthesis of solanum glycosides |
Non-Patent Citations (6)
Title |
---|
A. FÜRSTNER ET AL.: "Ring-closing alkyne metathesis. Application to the total synthesis of sophorolipid lactone", J.ORG.CHEM., vol. 65, 2000, pages 8758 - 8762, XP002292185 * |
FEWELL A M ET AL: "INTERACTIONS BETWEEN THE GLYCOALKALOIDS SOLASONINE AND SOLAMARGINE IN RELATION TO INHIBITION OF FUNGAL GROWTH", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 37, no. 4, 1994, pages 1007 - 1011, XP008011328, ISSN: 0031-9422 * |
FIGUEROA-PEREZ S ET AL: "Synthesis of a sialyl-alpha-(2->6)-lactosamine trisaccharide with a 5-amino-3-oxapentyl spacer group at C-1<I>", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, vol. 317, no. 1-4, 30 April 1999 (1999-04-30), pages 29 - 38, XP004179992, ISSN: 0008-6215 * |
L. F. AWAD ET AL.: "A synthesis of 3-O-(alpha-D-mannopyranosyl)-D-mannose and its protein conjugate", CARBOHYDRATE RESEARCH, vol. 122, no. 1, 1983, pages 69 - 79, XP002292126 * |
LI B ET AL: "An improved synthesis of the saponin, polyphyllin D", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, vol. 331, no. 1, 9 March 2001 (2001-03-09), pages 1 - 7, XP004317141, ISSN: 0008-6215 * |
SUGIYAMA S DIAKUR J M: "A convenient preparation fo glycosyl chlorides from Aryl/Alkyl thiogl", ORGANIC LETTERS, ACS, WASHINGTON, DC, US, vol. 2, no. 17, 2000, pages 2713 - 2715, XP002956970, ISSN: 1523-7060 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005454A1 (en) * | 2003-07-08 | 2005-01-20 | Glycomed Sciences Limited | Steroid modified chacotrioses and solatrioses |
WO2005005449A2 (en) * | 2003-07-08 | 2005-01-20 | Glycomed Sciences Limited | Steroid modified solatrioses |
WO2005005449A3 (en) * | 2003-07-08 | 2005-04-21 | Glycomed Sciences Ltd | Steroid modified solatrioses |
Also Published As
Publication number | Publication date |
---|---|
JP2006524664A (en) | 2006-11-02 |
US20080039628A1 (en) | 2008-02-14 |
US7435816B2 (en) | 2008-10-14 |
CA2524131A1 (en) | 2004-11-11 |
AU2004234071A1 (en) | 2004-11-11 |
EP1618122A1 (en) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pellissier | The glycosylation of steroids | |
Tang et al. | Structure, bioactivity, and chemical synthesis of OSW-1 and other steroidal glycosides in the genus Ornithogalum | |
WO2015081778A1 (en) | Method for synthesizing saponin | |
US7435816B2 (en) | Synthesis of solanum glycosides | |
EP1421100B1 (en) | Chemical synthesis of solamargine | |
JPH0826064B2 (en) | Method for producing steroid peracyl glycosides | |
AU2002336998A1 (en) | Synthesis of solanum glycosides | |
Pakulski | Recent progress in the glycosylation of lupanes | |
EP1654271B1 (en) | Steroid modified solatrioses | |
Suhr et al. | Synthesis of rhamnosylated diosgenyl glucosides as mimetics of cytostatic steroidal saponins from Ornithogalum saundersiae and Galtonia candicans | |
JP2005502671A5 (en) | ||
US5530107A (en) | Method for making steroidal peracyl glycosides | |
US20110054156A1 (en) | Synthesis of timosaponin bii | |
US20090012013A9 (en) | Steroid modified solatrioses | |
US3387006A (en) | 17beta-fluoroalkoxy-3-ketoestrenes | |
DE1468307A1 (en) | 2'-Acylamido-2'-deoxy-glucosides of 11,17,21-trihydroxy-pregnan-20-ones which are unsaturated in the ring A and are linked in the 21-position and process for their preparation | |
Bowdy | Toward the synthesis of CAY-1, an antifungal steroidal saponin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004234071 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004730531 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2524131 Country of ref document: CA Ref document number: 2006505349 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2004234071 Country of ref document: AU Date of ref document: 20040430 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004234071 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004730531 Country of ref document: EP |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10555038 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10555038 Country of ref document: US |